ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Omthera Pharmaceuticals, Inc. 



New York  New York    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Omthera Pharmaceuticals, Inc. Stockholders Approve Acquisition by AstraZeneca PLC (AZN) 7/16/2013 10:58:46 AM    More...
Omthera Pharmaceuticals, Inc. Announces Waiver of Lock-Up Restriction 7/11/2013 9:42:36 AM    More...
Omthera Pharmaceuticals, Inc. Announces NDA Submission for Epanova™ for the Treatment of Patients With Very High Triglycerides 7/9/2013 9:22:45 AM    More...
Omthera Pharmaceuticals, Inc. Announces Termination of Antitrust Waiting Period 6/27/2013 11:02:37 AM    More...
Omthera Pharmaceuticals, Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders 6/13/2013 2:13:35 PM    More...
Omthera Pharmaceuticals, Inc. Announces First Quarter 2013 Financial Results 5/28/2013 7:33:26 AM    More...
AstraZeneca PLC (AZN) Boosts Heart Drug Biz With $443 Million Omthera Pharmaceuticals, Inc. Buy 5/28/2013 7:07:10 AM    More...
Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering 4/17/2013 9:11:21 AM    More...
Omthera Pharmaceuticals, Inc. Prices Upsized IPO Below the Range at $8 4/11/2013 8:23:12 AM    More...
Omthera Pharmaceuticals, Inc. Files for a $75 Million IPO 3/11/2013 8:59:43 AM    More...
1234